ALK-AbellóCompany Review & Valuation

ALK-B
Copenhagen Stock Exchange
Latest Price
2,368.00DKK
Market Capitalization
23.41bDKK

About ALK-Abelló A/S

ALK-Abell√≥ A/S, a pharmaceutical company, develops, manufactures, and sells a range of products for the diagnosis, prevention, and treatment of respiratory allergy and allergic asthma in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of inj‚Ķ Show more ections, as well as sublingual drops and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company markets its products primarily under the ACARIZAX/ODACTRA, MITICURE, RAGWITEK, and GRAZAX/GRASTEK brand names. ALK-Abell√≥ A/S was founded in 1923 and is headquartered in H√łrsholm, Denmark. Show less

Industry
HQ Location
H√łrsholm, Denmark
Website

Stock Price

Price data not available for ALK-Abelló.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

back to top